American Century Companies’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-328,920
| Closed | -$5.21M | – | 2918 |
|
2024
Q4 | $5.21M | Buy |
328,920
+31,251
| +10% | +$495K | ﹤0.01% | 1586 |
|
2024
Q3 | $17.3M | Sell |
297,669
-501
| -0.2% | -$29.1K | 0.01% | 1087 |
|
2024
Q2 | $13.6M | Buy |
298,170
+59,364
| +25% | +$2.71M | 0.01% | 1116 |
|
2024
Q1 | $15.8M | Buy |
238,806
+24,209
| +11% | +$1.6M | 0.01% | 1019 |
|
2023
Q4 | $8.53M | Buy |
214,597
+523
| +0.2% | +$20.8K | 0.01% | 1211 |
|
2023
Q3 | $6.82M | Buy |
214,074
+71
| +0% | +$2.26K | 0.01% | 1218 |
|
2023
Q2 | $8.6M | Buy |
214,003
+100,860
| +89% | +$4.05M | 0.01% | 1122 |
|
2023
Q1 | $4.82M | Buy |
+113,143
| New | +$4.82M | ﹤0.01% | 1275 |
|